Dr Ted Stelmasiak
With over 25 years of experience in the biopharmaceutical industry, Dr Stelmasiak (DVM, PhD, MACVSc) founded Glutagen to provide solutions for people suffering symptoms due to gluten intolerance. Having held appointments with the Polish Academy of Sciences (Warsaw), the Imperial Cancer Research Fund (London), The University of Hawaii, Honolulu (USA), the University of Melbourne and the Victorian Institute of Animal Science (AU), Dr Stelmasiak has published over 60 scientific papers, filed several patents and developed treatments for bacterial and viral gastroenteritis.
Professor Hugh Cornell
Lead Consultant Biochemist
Prof. Cornell (PhD, FRACI) is a former Professor of Biological Chemistry at the RMIT University in Melbourne, AU, with a distinguished international career spanning over 40 years in gluten intolerance and coeliac disease research. Prof. Cornell has authored over 100 published scientific papers and presentations and has held appointments at Birmingham University (UK), University of Zurich (Switzerland), Karolinska Institute (Sweden) and Technical University (Germany). Prof. Cornell conducted founding work on the enzyme deficiency hypothesis in coeliac disease and holds several patents.